Given the increasingly appreciated role of astrocytes in synaptic pruning during neurodegeneration (Liddelow et al., 2017), further studies may help to elucidate why this effect appears to be limited to non-hippocampal regions and how astrocyte-related metabolic disarray leads to tau pathology in AD. This evidence concerns the gene MAPT and Alzheimer disease.